Regenerative Medicine News: U.S. FDA Grants 510(K) Clearance to DermiSphere hDRT for Wound Healing
The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for FesariusTherapeutics Inc’s DermiSphere hydrogelDermal Regeneration Template (DermiSphere hDRT). This technology represents a new class of collagen-based dermal matrices designed for tissue integration and revascularization for improved wound healing, reduction of time to healing, and better patient outcomes in the treatment of full-thickness wounds. DermiSphere hDRT is a […]